The Consolidation Of Talent, Capital and Returns in Biotech
lifescivc.com
lifescivc.com
MA will pull away with the lead soon from Bay Area
based on cost of living. I have senior management
members tell me daily that they'll move anywhere
BUT Bay Area. You'll pay $3.2m for 3/4 BR in Palo
Alto. South Bay and North Bay aren't too much better.For biotech deals, Boston does.
http://www.fiercebiotech.com/venture-capital/top-15-cities-f...
It's been an interesting change. 10 years ago, SF was the clear leader, but Boston has really moved up.
The use of 'data' to mean 'plural of datum' continues to fall out of favor in modern usage. Encountering it in a Saturday-morning browse was a note of angelic harmony to start the day.
'"Data are" doesn't roll of their tongues smoothly. But for British readers the plural is more natural.' [0]
[0] https://www.economist.com/blogs/graphicdetail/2012/07/point-...
BTW I looked you up. Do you know anything about Richard Muller's ideas for realising table-top detectors of gravitational waves?
Regarding Richard Muller's proposals: I don't -- confusingly, I am familiar with Holger Müller's proposals, and it would appear that they are both at Berkeley.
Experiment is the arbiter of truth; whenever any new instrumentation can demonstrably reach the relevant sensitivity and systematic-effect rejection necessary to do a job better than it has been done before, we'll all switch to it.
I'm going to go out on a limb here and say, maybe there are fewer biotech startups in Europe because profiting off of people's illnesses is generally frowned upon?
My guess is progress in that area falls more into the realm of government grants, with maybe the exception of classical pharmaceuticals (there are plenty of old companies like Bayer).
Biotech is not my field so I'd be interested in hearing other people's opinions.